Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 282

1.

Clinical Outcomes of Portosystemic shunts on the short term Outcome of Liver Transplantation.

Rodriguez EA, Perez R, Zhang N, Lim ES, Miller C, Schwartz MA, McGirr AJ, Srinivasan A, Hewitt W, Silva AC, Rakela J, Vargas HE.

Liver Transpl. 2019 Dec 24. doi: 10.1002/lt.25710. [Epub ahead of print]

PMID:
31872966
2.

Whole Exome Sequencing Among 26 Patients With Indeterminate Acute Liver Failure: A Pilot Study.

Rakela J, Rule J, Ganger D, Lau J, Cunningham J, Dehankar M, Baheti S, Lee WM; Acute Liver Failure Study Group.

Clin Transl Gastroenterol. 2019 Oct;10(10):e00087. doi: 10.14309/ctg.0000000000000087.

3.

Pilot evaluation of PD-1 inhibition in metastatic cancer patients with a history of liver transplantation: the Mayo Clinic experience.

DeLeon TT, Salomao MA, Aqel BA, Sonbol MB, Yokoda RT, Ali AH, Moss AA, Mathur AK, Chascsa DM, Rakela J, Bryce AH, Borad MJ.

J Gastrointest Oncol. 2018 Dec;9(6):1054-1062. doi: 10.21037/jgo.2018.07.05.

4.

Acute Liver Failure of Indeterminate Etiology: A Comprehensive Systematic Approach by An Expert Committee to Establish Causality.

Ganger DR, Rule J, Rakela J, Bass N, Reuben A, Stravitz RT, Sussman N, Larson AM, James L, Chiu C, Lee WM; Acute Liver Failure Study Group.

Am J Gastroenterol. 2018 Sep;113(9):1319. doi: 10.1038/s41395-018-0160-2. Epub 2018 Jun 27.

PMID:
29946176
5.

Thomas E. Starzl, M.D., Ph.D. (1926-2017).

Rakela J, Fung JJ.

Hepatology. 2017 Jul;66(1):306-308. doi: 10.1002/hep.29214. Epub 2017 Jun 7. No abstract available.

PMID:
28407325
6.

 Right hepatic lobe resection and thrombocytopenia.

Adike A, Rakela J, Czaplicki C, Moss A, Carey E.

Ann Hepatol. 2017 Jan-Feb 2017;16(1):10-11. doi: 10.5604/16652681.1226810.

7.

Corrigendum: Clinical Features and Outcomes of Complementary and Alternative Medicine Induced Acute Liver Failure and Injury.

Hillman L, Gottfried M, Whitsett M, Rakela J, Schilsky M, Lee WM, Ganger D.

Am J Gastroenterol. 2016 Oct;111(10):1504. doi: 10.1038/ajg.2016.349. No abstract available.

PMID:
27694861
8.

Loco-regional therapies for patients with hepatocellular carcinoma awaiting liver transplantation: Selecting an optimal therapy.

Byrne TJ, Rakela J.

World J Transplant. 2016 Jun 24;6(2):306-13. doi: 10.5500/wjt.v6.i2.306. Review.

9.

Clinical Features and Outcomes of Complementary and Alternative Medicine Induced Acute Liver Failure and Injury.

Hillman L, Gottfried M, Whitsett M, Rakela J, Schilsky M, Lee WM, Ganger D.

Am J Gastroenterol. 2016 Jul;111(7):958-65. doi: 10.1038/ajg.2016.114. Epub 2016 Apr 5. Erratum in: Am J Gastroenterol. 2016 Oct;111(10 ):1504.

10.

Acute liver failure associated with Garcinia cambogia use.

Corey R, Werner KT, Singer A, Moss A, Smith M, Noelting J, Rakela J.

Ann Hepatol. 2016 Jan-Feb;15(1):123-6.

11.

Hepatitis E virus serum antibodies and RNA prevalence in patients evaluated for heart and kidney transplantation.

Unzueta A, Valdez R, Chang YH, Desmarteau YM, Heilman RL, Scott RL, Douglas DD, Rakela J.

Ann Hepatol. 2016 Jan-Feb;15(1):33-40.

12.

Progenitor cell markers predict outcome of patients with hepatocellular carcinoma beyond Milan criteria undergoing liver transplantation.

Miltiadous O, Sia D, Hoshida Y, Fiel MI, Harrington AN, Thung SN, Tan PS, Dong H, Revill K, Chang CY, Roayaie S, Byrne TJ, Mazzaferro V, Rakela J, Florman S, Schwartz M, Llovet JM.

J Hepatol. 2015 Dec;63(6):1368-77. doi: 10.1016/j.jhep.2015.07.025. Epub 2015 Jul 26.

13.

microRNA changes in liver tissue associated with fibrosis progression in patients with hepatitis C.

Van Keuren-Jensen KR, Malenica I, Courtright AL, Ghaffari LT, Starr AP, Metpally RP, Beecroft TA, Carlson EW, Kiefer JA, Pockros PJ, Rakela J.

Liver Int. 2016 Mar;36(3):334-43. doi: 10.1111/liv.12919. Epub 2015 Sep 9.

14.

Magnetic resonance elastography can discriminate normal vs. abnormal liver biopsy in candidates for live liver donation.

Gallegos-Orozco JF, Silva AC, Batheja MJ, Chang YH, Hansen KL, Lam-Himlin D, De Petris G, Aqel BA, Byrne TJ, Carey EJ, Douglas DD, Mulligan DC, Silva AM, Rakela J, Vargas HE.

Abdom Imaging. 2015 Apr;40(4):795-802. doi: 10.1007/s00261-014-0310-y.

PMID:
25445158
15.

Relationship between sarcopenia, six-minute walk distance and health-related quality of life in liver transplant candidates.

Yadav A, Chang YH, Carpenter S, Silva AC, Rakela J, Aqel BA, Byrne TJ, Douglas DD, Vargas HE, Carey EJ.

Clin Transplant. 2015 Feb;29(2):134-41. doi: 10.1111/ctr.12493. Epub 2015 Jan 9.

PMID:
25430554
16.

Complementary and alternative medicine: risks and special considerations in pretransplant and posttransplant patients.

Corey RL, Rakela J.

Nutr Clin Pract. 2014 Jun;29(3):322-31. doi: 10.1177/0884533614528007. Epub 2014 Apr 7. Review.

PMID:
24710858
17.

Vitamin D deficiency, parathyroid hormone levels, and bone disease among patients with end-stage liver disease and normal serum creatinine awaiting liver transplantation.

Corey RL, Whitaker MD, Crowell MD, Keddis MT, Aqel B, Balan V, Byrne T, Carey E, Douglas DD, Harrison ME, Vargas HE, Rakela J.

Clin Transplant. 2014 May;28(5):579-84. doi: 10.1111/ctr.12351. Epub 2014 Apr 21.

PMID:
24628047
18.

Cellular therapy for liver disease.

Huebert RC, Rakela J.

Mayo Clin Proc. 2014 Mar;89(3):414-24. doi: 10.1016/j.mayocp.2013.10.023. Review.

19.

New Onset Diabetes Mellitus in Living Donor versus Deceased Donor Liver Transplant Recipients: Analysis of the UNOS/OPTN Database.

Yadav AD, Chang YH, Aqel BA, Byrne TJ, Chakkera HA, Douglas DD, Mulligan DC, Rakela J, Vargas HE, Carey EJ.

J Transplant. 2013;2013:269096. doi: 10.1155/2013/269096. Epub 2013 Sep 24.

20.

Hepatitis E infection in liver transplant recipients.

Unzueta A, Rakela J.

Liver Transpl. 2014 Jan;20(1):15-24. Review.

21.

Portal vein thrombosis in patients with end stage liver disease awaiting liver transplantation: outcome of anticoagulation.

Werner KT, Sando S, Carey EJ, Vargas HE, Byrne TJ, Douglas DD, Harrison ME, Rakela J, Aqel BA.

Dig Dis Sci. 2013 Jun;58(6):1776-80. doi: 10.1007/s10620-012-2548-y. Epub 2013 Jan 12.

PMID:
23314858
22.

Pretransplant fasting glucose predicts new-onset diabetes after liver transplantation.

Carey EJ, Aqel BA, Byrne TJ, Douglas DD, Rakela J, Vargas HE, Moss AA, Mulligan DC, Reddy KS, Chakkera HA.

J Transplant. 2012;2012:614781. doi: 10.1155/2012/614781. Epub 2012 Jan 29.

23.

Successful rituximab therapy in refractory autoimmune hepatitis and Evans syndrome.

Carey EJ, Somaratne K, Rakela J.

Rev Med Chil. 2011 Nov;139(11):1484-7. doi: /S0034-98872011001100015. Epub 2012 Feb 8.

24.

Evidence for liver injury in the setting of obstructive sleep apnea.

Byrne TJ, Parish JM, Somers V, Aqel BA, Rakela J.

Ann Hepatol. 2012 Mar-Apr;11(2):228-31.

25.

Monoclonal gammopathy of undetermined significance does not affect outcomes in patients undergoing solid organ transplants.

Jimenez-Zepeda VH, Heilman RL, Engel RA, Carey EJ, Freeman C, Rakela J, Mulligan DC, Fonseca R, Stewart AK.

Transplantation. 2011 Sep 15;92(5):570-4. doi: 10.1097/TP.0b013e318225db2c.

PMID:
21712755
26.

Six-minute walk distance predicts mortality in liver transplant candidates.

Carey EJ, Steidley DE, Aqel BA, Byrne TJ, Mekeel KL, Rakela J, Vargas HE, Douglas DD.

Liver Transpl. 2010 Dec;16(12):1373-8. doi: 10.1002/lt.22167.

27.

Gene therapy and enhancement for diabetes (and other diseases): the multiplicity of considerations.

Bertolaso M, Olsson J, Picardi A, Rakela J.

Diabetes Metab Res Rev. 2010 Oct;26(7):520-4. doi: 10.1002/dmrr.1116. Review.

PMID:
20818805
28.

Short-term cardiac and noncardiac mortality following liver transplantation.

Eleid MF, Hurst RT, Vargas HE, Rakela J, Mulligan DC, Appleton CP.

J Transplant. 2010;2010. pii: 910165. doi: 10.1155/2010/910165. Epub 2010 Aug 12.

29.

Treatment of hepatitis C in renal transplantation candidates: a single-center experience.

Werner T, Aqel B, Balan V, Byrne T, Carey E, Douglas D, Heilman RL, Rakela J, Mekeel K, Reddy K, Vargas HE.

Transplantation. 2010 Aug 27;90(4):407-11. doi: 10.1097/TP.0b013e3181e72837.

PMID:
20571469
30.

Natural history of post-liver transplantation hepatitis C: A review of factors that may influence its course.

Gallegos-Orozco JF, Yosephy A, Noble B, Aqel BA, Byrne TJ, Carey EJ, Douglas DD, Mulligan D, Moss A, de Petris G, Williams JW, Rakela J, Vargas HE.

Liver Transpl. 2009 Dec;15(12):1872-81. doi: 10.1002/lt.21954.

31.

A message from the editors: Thank you.

Rakela J, Fung JF.

Liver Transpl. 2009 Dec;15(12):1657. doi: 10.1002/lt.21950. No abstract available.

32.

An unusual occurrence of giant cell hepatitis.

Singh V, Rudraraju M, Carey EJ, Byrne TJ, Douglas DD, Rakela J, Vargas HE.

Liver Transpl. 2009 Dec;15(12):1888-90. doi: 10.1002/lt.21881. No abstract available.

33.

Safety studies on intrahepatic or intratumoral injection of oncolytic vesicular stomatitis virus expressing interferon-beta in rodents and nonhuman primates.

Jenks N, Myers R, Greiner SM, Thompson J, Mader EK, Greenslade A, Griesmann GE, Federspiel MJ, Rakela J, Borad MJ, Vile RG, Barber GN, Meier TR, Blanco MC, Carlson SK, Russell SJ, Peng KW.

Hum Gene Ther. 2010 Apr;21(4):451-62. doi: 10.1089/hum.2009.111.

34.

Severe hepatotoxicity caused by a methasteron-containing performance-enhancing supplement.

Singh V, Rudraraju M, Carey EJ, Byrne TJ, Vargas HE, Williams JE, Balan V, Douglas DD, Rakela J.

J Clin Gastroenterol. 2009 Mar;43(3):287. doi: 10.1097/MCG.0b013e31815a5796. No abstract available.

PMID:
18813027
35.

Erythropoietin does not increase the frequency of thromboembolic events or hepatocellular carcinoma in hepatitis C patients treated with combination antiviral therapy.

Gallegos-Orozco JF, Werner KT, Rosati M, Byrne TJ, Balan V, Vargas HE, Rakela J.

Am J Gastroenterol. 2008 Aug;103(8):2161-2. doi: 10.1111/j.1572-0241.2008.01982_18.x. No abstract available.

PMID:
18796126
36.

Long-term outcome of human leukocyte antigen mismatching in liver transplantation: results of the National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database.

Balan V, Ruppert K, Demetris AJ, Ledneva T, Duquesnoy RJ, Detre KM, Wei YL, Rakela J, Schafer DF, Roberts JP, Everhart JE, Wiesner RH.

Hepatology. 2008 Sep;48(3):878-88. doi: 10.1002/hep.22435.

PMID:
18752327
37.

Persistence of hepatitis C virus in peripheral blood mononuclear cells of sustained viral responders to pegylated interferon and ribavirin therapy.

Gallegos-Orozco JF, Rakela J, Rosati MJ, Vargas HE, Balan V.

Dig Dis Sci. 2008 Sep;53(9):2564-8. doi: 10.1007/s10620-008-0323-x. Epub 2008 Jul 2.

PMID:
18594984
38.

Living donor liver transplantation in polycystic liver disease.

Mekeel KL, Moss AA, Reddy KS, Douglas DD, Vargas HE, Carey EJ, Byrne TJ, Harrison ME, Rakela J, Mulligan DC.

Liver Transpl. 2008 May;14(5):680-3. doi: 10.1002/lt.21423.

39.

Inpatient admissions for drug-induced liver injury: results from a single center.

Carey EJ, Vargas HE, Douglas DD, Balan V, Byrne TJ, Harrison ME, Rakela J.

Dig Dis Sci. 2008 Jul;53(7):1977-82. doi: 10.1007/s10620-008-0250-x. Epub 2008 Apr 5.

PMID:
18392678
40.

Hepatic steatosis in chronic hepatitis C: baseline host and viral characteristics and influence on response to therapy with peginterferon alpha-2a plus ribavirin.

Reddy KR, Govindarajan S, Marcellin P, Bernstein D, Dienstag JL, Bodenheimer H Jr, Rakela J, Messinger D, Schmidt G, Ackrill A, Hadziyannis SJ.

J Viral Hepat. 2008 Feb;15(2):129-36. doi: 10.1111/j.1365-2893.2007.00901.x.

PMID:
18184196
41.

Conflict of interest policy.

Lindor K, Rakela J, Fung J.

Hepatology. 2008 Jan;47(1):1. No abstract available.

PMID:
18161724
42.

Liver transplantation in China.

Rakela J, Fung JJ.

Liver Transpl. 2007 Feb;13(2):182. No abstract available.

43.

Pegylated interferon and ribavirin failures: is retreatment an option?

Cheruvattath R, Rosati MJ, Gautam M, Vargas HE, Rakela J, Balan V.

Dig Dis Sci. 2007 Mar;52(3):732-6.

PMID:
17253142
44.

Liver transplantation in the MELD era: a single-center experience.

Sachdev M, Hernandez JL, Sharma P, Douglas DD, Byrne T, Harrison ME, Mulligan D, Moss A, Reddy K, Vargas HE, Rakela J, Balan V.

Dig Dis Sci. 2006 Jun;51(6):1070-8.

PMID:
16865573
45.

Selection of different 5' untranslated region hepatitis C virus variants during post-transfusion and post-transplantation infection.

Gallegos-Orozco JF, Arenas JI, Vargas HE, Kibler KV, Wilkinson JK, Nowicki M, Radkowski M, Nasseri J, Rakela J, Laskus T.

J Viral Hepat. 2006 Jul;13(7):489-98.

PMID:
16792543
47.

Living donor liver transplantation for hepatitis C-related cirrhosis: no difference in histological recurrence when compared to deceased donor liver transplantation recipients.

Guo L, Orrego M, Rodriguez-Luna H, Balan V, Byrne T, Chopra K, Douglas DD, Harrison E, Moss A, Reddy KS, Williams JW, Rakela J, Mulligan D, Vargas HE.

Liver Transpl. 2006 Apr;12(4):560-5.

48.

Differential display analysis of gene expression in brains from hepatitis C-infected patients.

Adair DM, Radkowski M, Jablonska J, Pawelczyk A, Wilkinson J, Rakela J, Laskus T.

AIDS. 2005 Oct;19 Suppl 3:S145-50.

PMID:
16251812
49.

Emerging evidence of hepatitis C virus neuroinvasion.

Laskus T, Radkowski M, Adair DM, Wilkinson J, Scheck AC, Rakela J.

AIDS. 2005 Oct;19 Suppl 3:S140-4. Review.

PMID:
16251811
50.

Presence of hepatitis C virus (HCV) RNA in the genital tracts of HCV/HIV-1-coinfected women.

Nowicki MJ, Laskus T, Nikolopoulou G, Radkowski M, Wilkinson J, Du WB, Rakela J, Kovacs A.

J Infect Dis. 2005 Nov 1;192(9):1557-65. Epub 2005 Sep 29.

Supplemental Content

Loading ...
Support Center